Location History:
- Cambridge, GB (2015 - 2016)
- Cambridgeshire, GB (2017 - 2020)
Company Filing History:
Years Active: 2015-2020
Title: Innovations of Angela Glen in Pharmaceutical Chemistry
Introduction
Angela Glen is a prominent inventor based in Cambridgeshire, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target orexin receptors. With a total of five patents to her name, her work has the potential to impact therapeutic approaches for various conditions.
Latest Patents
Among her latest patents, Angela has developed 1,2-substituted cyclopentanes as orexin receptor antagonists. The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein L, X, R, R, R, R, and R are defined in the specification. This invention also includes processes for their preparation, pharmaceutical compositions containing them, and their use in therapy.
Career Highlights
Angela Glen is currently associated with Takeda Pharmaceutical Company Limited, where she continues to innovate and contribute to the field. Her expertise in pharmaceutical chemistry has positioned her as a valuable asset within the company.
Collaborations
Angela has collaborated with notable colleagues, including Charlotte Fieldhouse and Tatsuhiko Fujimoto. These partnerships have further enhanced her research and development efforts in the pharmaceutical industry.
Conclusion
Angela Glen's work exemplifies the innovative spirit of modern pharmaceutical research. Her contributions to the development of orexin receptor antagonists highlight her commitment to advancing therapeutic options.